文献速递儿童感染儿童血液肿瘤与免疫

三价灭活流感疫苗对急性白血病儿童的有效性

The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia.
PubMed 文献 · J Pediatr · 2017-01-01

该回顾性研究分析了498例接受急性白血病治疗的儿童和青少年患者,在2010-2011至2012-2013三个连续流感季节中的数据。结果显示,接种三价灭活流感疫苗(TIV)与未接种者在实验室确诊流感和流感样疾病(ILI)的发生率上均无差异,且接种1剂与2剂之间也无差异。结论认为TIV未能保护该人群免受流感和ILI。

要点

  • 在急性白血病儿童中,接种TIV与未接种者的流感及ILI发生率无差异。
  • 接种1剂与2剂TIV的患者之间,流感或ILI发生率也无差异。
  • TIV未延长至首次流感感染或首次ILI的时间。

核心结论

  • TIV未能保护接受治疗的急性白血病儿童和青少年免受实验室确诊流感和流感样疾病。

研究设计与样本

  • 回顾性研究,纳入某儿童癌症中心2010-2011至2012-2013三个连续流感季节期间接受急性白血病治疗的498例患者。

主要发现

  • 498例患者季节中,354例(71.1%)接种TIV,98例(19.7%)接种加强剂。
  • 接种与未接种患者总体及任一季节的流感或ILI发生率均无差异。
  • 接种1剂与2剂疫苗的患者之间流感或ILI发生率无差异。
  • 接种与未接种患者至首次流感感染时间和至首次ILI时间均无差异。

关键数值与推荐

  • 接种TIV患者354例(71.1%),接种加强剂患者98例(19.7%)。
  • 中位年龄6岁(范围1-21岁)。

临床怎么用

  • 在急性白血病儿童中,不应仅依赖TIV预防流感,需考虑其他预防策略。

局限性

  • 回顾性设计;需未来前瞻性研究评估高风险亚群的TIV有效性及替代预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to determine the effectiveness of trivalent inactivated influenza vaccine (TIV) for the prevention of laboratory-confirmed influenza and influenza-like illnesses (ILI) among children and adolescents receiving therapy for acute leukemia. STUDY DESIGN: A retrospective review of the demographic and clinical characteristics of 498 patients at a pediatric cancer center who received therapy for acute leukemia during 3 successive influenza seasons (2010-2011 through 2012-2013). RESULTS: In 498 patient seasons with a known immunization history (median age, 6 years; range, 1-21), 354 patients (71.1%) were immunized with TIV and 98 (19.7%) received a booster dose of vaccine. Vaccinated and unvaccinated patients had generally similar demographic characteristics. There were no differences in the overall rates of influenza or ILI between vaccinated and unvaccinated patients overall, or in any individual season. There was no difference in the rates of influenza or ILI between patients who received 1 dose of vaccine and those who received 2 doses. Time to first influenza infection and time to first ILI in vaccinated and unvaccinated patients were not different. CONCLUSION: TIV did not protect children and adolescents with acute leukemia against laboratory-confirmed influenza or ILI. Future prospective studies should assess TIV effectiveness in high-risk subpopulations and alternative strategies to prevent influenza should be considered in this population.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Sykes A, Gerhardt E, Tang L, et al. The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia. J Pediatr. 2017. PMID: 29173310. doi:10.1016/j.jpeds.2017.08.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。